Literature DB >> 15109419

Patient data, early SARS epidemic, Taiwan.

Po-Ren Hsueh1, Pei-Jer Chen, Cheng-Hsiang Hsiao, Shiou-Huei Yeh, Wern-Cherng Cheng, Jiun-Ling Wang, Bor-Luen Chiang, Shan-Chwen Chang, Feng-Yee Chang, Wing-Wai Wong, Chuan-Liang Kao, Pan-Chyr Yang.   

Abstract

Of the first 10 patients in the epidemic of severe acute respiratory syndrome (SARS) in Taiwan, 4 were closely associated with a SARS patient in an airplane. Loose stools or diarrhea, hemophagocytosis syndrome, and high serum levels of interleukin (IL)-6, IL-8, and tumor necrosis factor-a associated with lung lesions were found in all 10 patients.

Entities:  

Mesh：

Year:  2004        PMID： 15109419     DOI： 10.3201/eid1003.030571

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  32 in total

1.  Serum cytokine responses in primary pneumonic plague patients.

Authors:  Xiaoyi Wang; Zuyun Wang; Zhaobiao Guo; Baiqing Wei; Fuzhang Tian; Shouhong Yu; Haoran Wang; Hu Wang; Ruifu Yang
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

Review 2.  Possible Mechanisms and Special Clinical Considerations of Curcumin Supplementation in Patients with COVID-19.

Authors:  Zinat Heidari; Marzieh Mohammadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.

Authors:  Pablo C Alarcon; Michelle S M A Damen; Rajat Madan; George S Deepe; Paul Spearman; Sing Sing Way; Senad Divanovic
Journal:  Mucosal Immunol       Date:  2021-05-06       Impact factor: 7.313

4.  SARS clinical features, United States, 2003.

Authors:  Padmini Srikantiah; Myrna D Charles; Sarah Reagan; Thomas A Clark; Mathias W R Pletz; Priti R Patel; Robert M Hoekstra; Jairam Lingappa; John A Jernigan; Marc Fischer
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

5.  Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus.

Authors:  Martin Spiegel; Friedemann Weber
Journal:  Virol J       Date:  2006-03-29       Impact factor: 4.099

Review 6.  Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.

Authors:  Caren J Stark; C D Atreya
Journal:  Virol J       Date:  2005-04-15       Impact factor: 4.099

7.  SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro.

Authors:  Susan F Dosch; Supriya D Mahajan; Arlene R Collins
Journal:  Virus Res       Date:  2009-01-29       Impact factor: 3.303

8.  A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.

Authors:  Craig W Day; Ralph Baric; Sui Xiong Cai; Matt Frieman; Yohichi Kumaki; John D Morrey; Donald F Smee; Dale L Barnard
Journal:  Virology       Date:  2009-10-22       Impact factor: 3.616

9.  Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients.

Authors:  Jann-Tay Wang; Wang-Huei Sheng; Chi-Tai Fang; Yee-Chun Chen; Jiun-Ling Wang; Chong-Jen Yu; Shan-Chwen Chang; Pan-Chyr Yang
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

Review 10.  Pathology and pathogenesis of severe acute respiratory syndrome.

Authors:  Jiang Gu; Christine Korteweg
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.